What is the diagnosis for a patient with leukopenia (low White Blood Cell (WBC) count), anemia (low Red Blood Cell (RBC) count, low hemoglobin, and low hematocrit), thrombocytosis (normal platelet count), and abnormal differential counts, including neutrophilia (high neutrophil percentage), lymphopenia (low lymphocyte percentage), and monocytosis (high monocyte percentage)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The patient's blood test results indicate a macrocytic anemia with multiple cytopenias, and I strongly recommend a hematology consultation to evaluate the cause of these abnormalities, as suggested by 1. The low white blood cell count (4.4 K/mcL), low red blood cell count (3.42 M/mcL), low hemoglobin (11.1 g/dL), and high mean corpuscular volume (MCV) of 100.6 fL indicate a macrocytic anemia, which is commonly seen in vitamin B12 or folate deficiency, certain medications, alcohol use, or liver disease, as noted in 1. The low absolute lymphocyte count (0.70 K/mcL) suggests some immune dysfunction. Further evaluation with vitamin B12 and folate levels, a peripheral blood smear, reticulocyte count, and liver function tests would be beneficial, as recommended in 1. Additionally, medication review and alcohol use assessment would be appropriate. A balanced diet rich in B vitamins and folate (leafy greens, legumes, fortified cereals) would be beneficial in the meantime. The macrocytosis (enlarged red blood cells) combined with anemia often indicates impaired DNA synthesis during red blood cell production, which affects cell division but not hemoglobin synthesis, resulting in fewer but larger red blood cells. Some key points to consider in the evaluation and management of this patient include:

  • Careful assessment of concomitant medications and comorbid conditions, as suggested in 1
  • Evaluation of the degree of dysplasia and potentially dysfunctional cells through a peripheral blood smear, as recommended in 1
  • Consideration of bone marrow aspiration and biopsy to evaluate the degree of hematopoietic cell maturation abnormalities, as noted in 1
  • Screening for paroxysmal nocturnal hemoglobinuria (PNH) and HLA-DR15, as suggested in 1
  • Review of peripheral smear to determine the presence of large granular lymphocytic disease, as recommended in 1.

From the Research

Blood Test Results

The provided blood test results show several parameters that are outside the normal range, including:

  • WBC (White Blood Cell count): 4.4 K/mcL, which is lower than the normal range of 4.6 - 10.2 K/mcL
  • RBC (Red Blood Cell count): 3.42 M/mcL, which is lower than the normal range of 3.74 - 5.34 M/mcL
  • Hemoglobin: 11.1 g/dL, which is lower than the normal range of 12.0 - 16.0 g/dL
  • Hematocrit: 34.4 %, which is lower than the normal range of 34.3 - 47.9 %
  • Lymphocytes Relative: 15.8 %, which is lower than the normal range of 17.9 - 49.6 %
  • Lymphocytes Absolute: 0.70 K/mcL, which is lower than the normal range of 1.00 - 4.80 K/mcL

Possible Causes and Treatments

According to the studies, anemia is a common condition that can be caused by various factors, including iron deficiency 2, 3, 4, 5, 6. The studies suggest that iron supplementation is essential to maximize the effect of erythropoiesis, especially in patients treated with epoetin alfa 3, 4, 5, 6. Some key points to consider:

  • Iron is an essential component of erythropoiesis, and virtually all patients receiving epoetin alfa will eventually require iron supplementation 3
  • Stimulation of erythropoiesis following the administration of epoetin alfa is associated with several changes in iron metabolism, including a decrease in plasma ferritin levels 4
  • Iron therapy is essential when using erythropoietin to maximize erythropoiesis by avoiding absolute and functional iron deficiency 5
  • Body iron stores are best maintained by providing 800-1200 mg of iron intravenously in a year, or more if blood loss is significant 5
  • Serum ferritin and transferrin iron saturation are the most common tests used to monitor iron therapy, but other tests such as measuring the percentage of hypochromic red blood cells and soluble transferrin receptor levels can also be used 5, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Anemia: Evaluation of Suspected Anemia.

FP essentials, 2023

Research

Iron requirements in erythropoietin therapy.

Best practice & research. Clinical haematology, 2005

Research

Iron management during recombinant human erythropoietin therapy.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 1989

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.